This website is intended for a U.S. audience only
Pipeline Overview
Our portfolio of development programs targets prevalent food allergies.
Program
Pre-ind
Phase 1
Phase 2
Phase 3
Approved
Phase
PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp]
Approved
PALFORZIA® POSEIDON Study
PH 3
PALFORZIA® + adjunctive dupilumab
PH 2
AR201* (EGG)
PH 2
AR401* (MULTI-TREE NUT)
PRE-IND
AIMab7195
PRE-IND
*These product candidates are based on foods that have not shown toxicology issues except in their functions as allergens; we have not been required to and at this time do not anticipate conducting Phase 1 clinical trials.